Cancer of Unknown Primary Sites: What Radiologists Need to Know and What Oncologists Want to Know
被引:24
|
作者:
Kim, Kyung Won
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USA
Seoul Asan Med Ctr, Dept Radiol, Seoul, South KoreaHarvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USA
Kim, Kyung Won
[1
,2
]
Krajewski, Katherine M.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USAHarvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USA
Krajewski, Katherine M.
[1
]
Jagannathan, Jyothi P.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USAHarvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USA
Jagannathan, Jyothi P.
[1
]
Nishino, Mizuki
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USAHarvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USA
Nishino, Mizuki
[1
]
Shinagare, Atul B.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USAHarvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USA
Shinagare, Atul B.
[1
]
Hornick, Jason L.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USAHarvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USA
Hornick, Jason L.
[3
]
Ramaiya, Nikhil H.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USAHarvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USA
Ramaiya, Nikhil H.
[1
]
机构:
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USA
[2] Seoul Asan Med Ctr, Dept Radiol, Seoul, South Korea
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA
OBJECTIVE. In this article, we review the role of imaging in cancer of unknown primary site (CUP) diagnosis and management and the utility of immunohistochemistry, serum tumor markers, and molecular profiling in the optimized care of CUP patients. CONCLUSION. With advances in imaging, pathology, and molecular medicine, the diagnosis and management of CUP have evolved into more personalized and site-specific therapies. A multidisciplinary integrated approach among oncologists, pathologists, and radiologists is extremely important.